Clinical Trial Update: Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the efficacy and safety of intramuscular hepatitis B immune globulin (HBIG) from Grifols for preventing recurrence after liver transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBIG (hepatitis B immune globulin)

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED